Developing and Validating the CE-MACE Model to Predict One-Year Major Adverse Cardiovascular Events Post COPD...

Area of Science:

• Cardiology
• Pulmonology
• Epidemiology

Background:

• Patients with chronic obstructive pulmonary disease (COPD) have increased cardiovascular event risk, especially after exacerbations.
• Current prediction models often underestimate this risk.
• Cardiovascular multimorbidity is a significant concern in COPD management.

Purpose of the Study:

• To develop and validate the CE-MACE model for predicting one-year major adverse cardiovascular event (MACE) risk in COPD patients post-exacerbation.
• To improve the accuracy of cardiovascular risk assessment in this vulnerable population.

Main Methods:

• Utilized UK Clinical Practice Research Datalink (CPRD) Aurum database for electronic health records.
• Included patients aged ≥40 with moderate/severe COPD exacerbations.
• Employed cause-specific hazard models and internal-external cross-validation across nine regions.
• Assessed model performance using Nagelkerke's R², Harrell's C statistic, and calibration metrics.

Main Results:

• Included 338,981 patients; one-year MACE incidence was 5.04%.
• Six key predictors identified: age, exacerbation severity, MACE history, mMRC dyspnea scale, hypertension, and diabetes.
• CE-MACE demonstrated good performance (C-statistic 0.752) and clinical utility across risk thresholds.
• Model showed generalizability for patients with any COPD exacerbation history.

Conclusions:

• The CE-MACE model effectively predicts one-year MACE risk following COPD exacerbation.
• It aids in precise identification of high-risk individuals, facilitating integrated care.
• Highlights the substantial cardiovascular burden in COPD patients.